Nan Shan Life Insurance Co. Ltd. Buys 8,581 Shares of Intuitive Surgical, Inc. $ISRG

Nan Shan Life Insurance Co. Ltd. lifted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 11.1% in the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 86,062 shares of the medical equipment provider’s stock after purchasing an additional 8,581 shares during the quarter. Nan Shan Life Insurance Co. Ltd.’s holdings in Intuitive Surgical were worth $34,225,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of ISRG. Brighton Jones LLC increased its position in Intuitive Surgical by 24.9% during the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock valued at $1,916,000 after acquiring an additional 731 shares during the last quarter. Sivia Capital Partners LLC grew its holdings in Intuitive Surgical by 3.8% during the 2nd quarter. Sivia Capital Partners LLC now owns 928 shares of the medical equipment provider’s stock valued at $504,000 after purchasing an additional 34 shares during the last quarter. Schnieders Capital Management LLC. raised its position in Intuitive Surgical by 38.0% in the 2nd quarter. Schnieders Capital Management LLC. now owns 973 shares of the medical equipment provider’s stock worth $529,000 after purchasing an additional 268 shares during the period. Osterweis Capital Management Inc. purchased a new stake in shares of Intuitive Surgical in the second quarter worth approximately $200,000. Finally, Main Street Financial Solutions LLC lifted its stake in shares of Intuitive Surgical by 92.4% during the 2nd quarter. Main Street Financial Solutions LLC now owns 2,929 shares of the medical equipment provider’s stock worth $1,592,000 after acquiring an additional 1,407 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

ISRG has been the topic of a number of research analyst reports. Raymond James Financial restated an “outperform” rating and issued a $483.00 price target (down from $577.00) on shares of Intuitive Surgical in a report on Friday, July 17th. BNP Paribas Exane raised shares of Intuitive Surgical to an “outperform” rating in a research note on Tuesday, July 28th. Stifel Nicolaus lowered their price target on Intuitive Surgical from $670.00 to $550.00 and set a “buy” rating for the company in a report on Friday, July 17th. Robert W. Baird dropped their price objective on Intuitive Surgical from $525.00 to $500.00 and set an “outperform” rating on the stock in a research note on Friday, July 17th. Finally, Leerink Partners reduced their price objective on Intuitive Surgical from $573.00 to $454.00 and set an “outperform” rating on the stock in a report on Friday, July 17th. Twenty-two research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus price target of $508.68.

Intuitive Surgical Stock Down 2.0%

Intuitive Surgical stock opened at $369.25 on Wednesday. The firm has a market cap of $130.45 billion, a P/E ratio of 42.30, a P/E/G ratio of 2.72 and a beta of 1.47. The business has a fifty day moving average of $383.40 and a two-hundred day moving average of $430.61. Intuitive Surgical, Inc. has a twelve month low of $328.57 and a twelve month high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 EPS for the quarter, beating the consensus estimate of $2.48 by $0.32. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. The business had revenue of $2.89 billion during the quarter, compared to analyst estimates of $2.83 billion. During the same period in the prior year, the firm posted $1.81 earnings per share. The company’s quarterly revenue was up 18.4% on a year-over-year basis. Equities analysts expect that Intuitive Surgical, Inc. will post 8.87 earnings per share for the current year.

Insider Activity

In other Intuitive Surgical news, EVP Mark Brosius sold 77 shares of the firm’s stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $375.57, for a total value of $28,918.89. Following the completion of the sale, the executive vice president owned 881 shares of the company’s stock, valued at approximately $330,877.17. This trade represents a 8.04% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of the company’s stock in a transaction dated Monday, August 10th. The shares were sold at an average price of $379.00, for a total transaction of $151,600.00. Following the transaction, the executive vice president owned 5,320 shares in the company, valued at approximately $2,016,280. This trade represents a 6.99% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 11,658 shares of company stock valued at $4,649,835 in the last ninety days. 0.60% of the stock is currently owned by insiders.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.